Bp Plc increased its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 24.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,000 shares of the medical research company’s stock after acquiring an additional 12,000 shares during the period. Bp Plc’s holdings in Thermo Fisher Scientific were worth $10,644,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Proficio Capital Partners LLC grew its holdings in shares of Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after acquiring an additional 253 shares in the last quarter. Cribstone Capital Management LLC grew its holdings in Thermo Fisher Scientific by 8.7% during the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 50 shares during the period. Chicago Partners Investment Group LLC bought a new position in Thermo Fisher Scientific during the second quarter valued at $108,000. CWM LLC grew its holdings in Thermo Fisher Scientific by 17.0% during the second quarter. CWM LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after purchasing an additional 103 shares during the period. Finally, Sharkey Howes & Javer grew its holdings in Thermo Fisher Scientific by 1.0% during the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after purchasing an additional 7 shares during the period. 83.52% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: This story was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.chaffeybreeze.com/2017/09/17/thermo-fisher-scientific-inc-tmo-stake-boosted-by-bp-plc.html.
In related news, Director C Martin Harris sold 360 shares of the company’s stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the transaction, the director now owns 5,312 shares of the company’s stock, valued at approximately $961,312.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, VP Seth H. Hoogasian sold 4,140 shares of the company’s stock in a transaction on Monday, August 28th. The stock was sold at an average price of $177.80, for a total transaction of $736,092.00. Following the completion of the transaction, the vice president now directly owns 25,518 shares of the company’s stock, valued at approximately $4,537,100.40. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,738 shares of company stock valued at $4,021,512. Insiders own 0.49% of the company’s stock.
Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) opened at 190.63 on Friday. Thermo Fisher Scientific Inc. has a 52-week low of $139.07 and a 52-week high of $194.30. The stock has a market cap of $74.37 billion, a P/E ratio of 33.21 and a beta of 1.05. The firm’s 50 day moving average price is $180.21 and its 200 day moving average price is $170.53.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 12.27% and a return on equity of 11.11%. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter in the previous year, the firm posted $2.03 EPS. The company’s revenue for the quarter was up 10.2% compared to the same quarter last year. On average, analysts expect that Thermo Fisher Scientific Inc. will post $9.35 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s payout ratio is 10.45%.
Several brokerages have weighed in on TMO. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $214.00 price objective for the company in a report on Thursday. Cowen and Company reissued an “outperform” rating and set a $220.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Morgan Stanley reissued an “overweight” rating and set a $220.00 price objective on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Argus reissued a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Finally, BidaskClub lowered Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. One analyst has rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $193.56.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.